January Cannabis Sales Slip

New Cannabis Ventures offers readers this easy-to-read exclusive summary of BDSA’s monthly cannabis sales data for 11 states.

Cannabis sales decreased 7.0% sequentially in January after increasing 5.3% in December, according to cannabis data analytics firm BDSA. Looking at a per-day basis, sales decreased 7.0% sequentially, as the days in each month are the same. In this review, we will look at the markets one-by-one, beginning with the eastern markets and then concluding with the western markets. In total, BDSA estimates that sales across the 11 markets totaled $1.588 billion during the month.

Eastern Markets

BDSA provides coverage for Florida, Illinois, Maryland, Massachusetts, Michigan and Pennsylvania. In January, year-over-year growth ranged from -13.7% in Maryland to 36.8% in Michigan. Note that Florida, Maryland and Pennsylvania are medical-only markets, though Maryland is introducing adult-use soon.


Florida declined from a record December, falling 3.1% to $200.11 million, up 31.4% from a year ago. Unlike other states, flower, +46% from a year ago, was the strongest category. Concentrates were also strong at +42%.


This past week, Illinois posted data for January and for February, which we shared. Total sales estimated by BDSA were slightly lower at $154.91 million, down 11.6% sequentially and up 5.4% from a year ago. Pre-rolls led all of the categories, growing 15% from a year ago.


Sales fell 7.3% sequentially and 13.7% from a year ago to $37.98 million. Ingestibles were by far the best category, falling 1% from a year ago.


Sales in this state rose 3.1% from a year ago to $139.89 million, down 9.4% sequentially. Most categories were close to unchanged, but pre-rolls expanded 12% from a year ago.


We released data from the state in mid-February. The $207.3 million was down 6.5% sequentially but up 36.8% from a year ago. All categories expanded rapidly from a year ago, with pre-rolls, up 98%, leading the way.


The total sales of $91.03 million fell 3.3% sequentially and 11.3% from a year ago. Ingestibles, up 7% from a year ago, were the only category to gain.

Western Markets

BDSA provides coverage for Arizona, California, Colorado, Nevada and Oregon. In January, year-over-year growth ranged from -21.1% in Nevada to 3.4% in Arizona compared to a year ago.


Arizona’s total sales were $105.56 million, down 2.8% sequentially and up 3.4% from a year ago. Medical sales, totaling $34.9 million, fell 20% from a year ago and 10% sequentially, while adult-use sales grew 1% sequentially and 21% from a year ago to $70.6 million. Concentrates rose 5% from a year ago, while edibles gained 8%.  Pre-rolls increased 33%, and flower sales fell 6%.


California was revised historically by BDSA. Sales of $380 million were down 9.1% sequentially and 15.2% from a year ago. Pre-rolls, down 8% from a year ago, were the only category not to suffer double-digit declines.


Colorado sales fell less than recently, declining 11% to $134.5 million, down 3.3% sequentially. Concentrates and pre-rolls, down 7% from a year ago, performed better than flower and ingestibles.


Nevada remains crippled by the pandemic, with sales falling 21.1% from a year ago while increasing 0.4% sequentially to $61.02 million. All forms of cannabis were double-digit decliners from a year ago during the month.


Revenue fell 4.8% sequentially as it declined 9.8% from a year ago to $75.45 million. Flower sales dropped 24%, while pre-rolls gained 16%. Concentrates fell 5%, while ingestibles grew 5%.


For readers interested in a deeper look at cannabis markets across these eleven states and more, including segmentation by additional product categories, brand and item detail, longer history, and segmentation by product attributes, learn how BDSA Solutions can provide you with access to actionable data and analysis.

Exclusive article by Alan Brochstein, CFA
Alan Brochstein, CFA
Based in Houston, Alan leverages his experience as founder of online community 420 Investor, the first and still largest due diligence platform focused on the publicly-traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. At New Cannabis Ventures, he is responsible for content development and strategic alliances. Before shifting his focus to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst following over two decades in research and portfolio management. A prolific writer, with over 650 articles published since 2007 at Seeking Alpha, where he has 70,000 followers, Alan is a frequent speaker at industry conferences and a frequent source to the media, including the NY Times, the Wall Street Journal, Fox Business, and Bloomberg TV. Contact Alan: Twitter | Facebook | LinkedIn | Email

Get Our Sunday Newsletter